The Fund's investment objective is to provide long term capital growth by matching the capital performance of the FTSE World Europe excluding UK Index.
Name | % Net Assets |
---|---|
Nestle S.A. | 4.8% |
Novartis AG | 3.3% |
Roche Holding AG Part. Cert. | 2.7% |
Total S.A. | 2.3% |
Sanofi | 2.2% |
Siemens AG | 1.8% |
BASF AG | 1.6% |
Sanofi-Aventis S.A. | 1.4% |
LVMH Moet Hennessy Louis Vuitton SA | 1.3% |
Anheuser-Busch InBev | 1.3% |
Key | % Net Assets |
---|---|
Nestle S.A. | 4.8% |
Novartis AG | 3.3% |
Roche Holding AG Part. Cert. | 2.7% |
Total S.A. | 2.3% |
Other | 86.9% |
Date | 21-Nov-2024 |
---|---|
NAV | 1,429.00p |
Currency | GBP |
Change | -2.00p |
% | -0.14% |
YTD change | 30.00p |
YTD % | 2.14% |
Fund Inception | 14/01/1989 |
---|---|
Fund Manager | Sinopia Asset Management (UK) Ltd |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £1,000,000 |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research